Hi, I am a student in the US with Crohn's disease, and I am considering attending a university in the UK next year. I currently recieve Remicade (infliximab), mercaptopurine and pentasa for treatment. I know regulations may be different in the UK regarding these drugs, but are these drugs prescribed/used in the UK? I understand my care would be transferred from my current US doctor to a local gastroenterologist in the UK, and this doctor would ultimately make the decisions in my care regarding prescriptions. Thank you!
The medication you mentioned, Infliximab, Mercaptopurine, and Pentasa are readily available in the UK. They are prescribed here in the UK and are used by patients. With regard to the Infliximab, you currently receive the brand Remicade. In 2013, a biosimilar version of infliximab was authorised in UK as two brand names: Inflectra (Hospira UK) and Remsima ( marketed in the UK by Napp Pharmaceuticals). The pharmaceutical form, strength, therapeutic indications and dosing regimens of Inflectra and Remsima and Remicade are the same. Both Inflectra and Remsima were launched in the UK in February 2015.
Your care would be transferred from your current US doctor to a local gastroenterologist here in the UK. The doctor/specialist who would take the responsibility to issue you prescriptions for the relevant medication to manage your Crohn’s.
Please don’t hesitate to contact us here at AXA again if you need any more help. Wishing you best of luck in your studies.
Answered by the Health at Hand nurses